摘要
The phenyl-substituted analog of prostaglandin F2α , latanoprost ( Xalatan; Pfizer, Inc, New York, NY) is an intraocular pressure (IOP)-lowering drug for use in patients with glaucoma and ocular hypertension. Latanoprost has been sho wn to stimulate eyelash hypertrichosis and has recently been proposed as a possi ble treatment for alopecia areata involving the eyelashes. We report a case of h ypertrichosis of the eyelashes caused by the prostamide bimatoprost (Lumigan; Al lergan, Inc, Irvine, Calif), a new IOP-lowering drug.
The phenyl-substituted analog of prostaglandin F2α , latanoprost ( Xalatan; Pfizer, Inc, New York, NY) is an intraocular pressure (IOP)-lowering drug for use in patients with glaucoma and ocular hypertension. Latanoprost has been sho wn to stimulate eyelash hypertrichosis and has recently been proposed as a possi ble treatment for alopecia areata involving the eyelashes. We report a case of h ypertrichosis of the eyelashes caused by the prostamide bimatoprost (Lumigan; Al lergan, Inc, Irvine, Calif), a new IOP-lowering drug.
